SCNX Q1 2026 Earnings Significant EPS Beat Despite Lack of Revenue EYE Q1 2026 Earnings Earnings Beat Estimates Stock Moves Higher SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline ABEV Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh HCTI Q4 2025 Earnings Staggering EPS Miss Driven by Deepening Losses Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress